Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CADLCADL
Showing 8 of 20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CANDEL THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.6M shares of CADL (CANDEL THERAPEUTICS INC), worth $16.2M as of 2026-Q2. The position was increased (+51.7% shares). CADL represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$16.2M

Current Shares

1.6M

Total Value Change

+$13.1M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+51.7%
$16.2M0.0%$10.30
39
2026-Q1
Increased
1M
+5.9%
$5.1M0.0%$4.91
29
2025-Q4
Increased
977,512
+5.3%
$5.5M0.0%$5.71
29
2025-Q3
Increased
928,197
+2.7%
$4.7M0.0%$5.40
28
2025-Q2
Increased
903,970
+31.5%
$4.6M0.0%$4.90
34
2025-Q1
Increased
687,461
+51.0%
$3.9M0.0%$5.95
37
2024-Q4
Increased
455,424
+1.4%
$4M0.0%$7.95
27
2024-Q3
Increased
448,997
+12.8%
$3.1M0.0%$7.21
30

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used